The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of vitamin K dosing during sorafenib treatment for hepatocellular carcinoma: Effect on ischemic tumor cell damage caused by sorafenib.
 
Yoshimichi Haruna
No Relationships to Disclose
 
Noriko Hasegawa
No Relationships to Disclose
 
Kazuho Imanaka
No Relationships to Disclose
 
Atsuo Inoue
No Relationships to Disclose
 
Masatoshi Kudo
Honoraria - Ajinomoto; Bayer; Eisai; Kaken Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; Taiho Pharmaceutical
Research Funding - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; Lilly; Novartis/Pfizer; Taiho Pharmaceutical